HCV - Hepatocellular Carcinoma

Sustained Virological Response to Pegylated Interferon plus Ribavirin for Chronic Hepatitis C Does Not Always Prevent Hepatocellular Carcinoma - 10/10/08

STORM Trial to Assess Sorafenib (Nexavar) as Adjuvant Therapy for Patients with Liver Cancer - 9/12/2008

Hepatocellular Carcinoma Rates Vary Widely Across Sex and Racial/Ethnic Groups - 7/25/08

Two Studies Look at Promising Therapies for Liver Cancer - 7/25/08

Insulin Resistance and Diabetes Increase the Risk of Liver Fibrosis and Hepatocellular Carcinoma in People with Chronic Hepatitis C - 7/04/08

Insulin Resistance and Diabetes Increase the Risk of Liver Fibrosis and Hepatocellular Carcinoma in People with Chronic Hepatitis C - 6/24/08

Incidence of and Risk Factors for Hepatocellular Carcinoma in Hepatitis C Patients with Advanced Liver Disease: HALT-C Trial - 5/16/08

Sorafenib (Nexavar) Improves Outcomes in Patients with Hepatocellular Carcinoma - 5/16/08

Combination Therapy Improves Survival Time for Patients with Advanced Liver Cancer  - 4/11/08

Human Genetic Variation May Protect Against HCV-related Liver Disease Progression - 1/04/08

Diabetes Is a Risk Factor for Liver Cancer Recurrence after Surgery in Patients with Viral Hepatitis    - 7/13/07

New Drug for Treatment of Liver Cancer    - 6/12/07

Colchicine Delays the Development of Hepatocellular Carcinoma in Patients with Chronic Viral Hepatitis 10/13/06

Mutation Patterns and Genotypes Associated with Hepatocellular Carcinoma in HBV/HCV Coinfected Patients   - 9/01/06

Long-term Effect of Interferon/Ribavirin on Incidence of Hepatocellular Carcinoma - 8/15/06